The Little Princess Trust (LPT) has announced seven new innovative childhood cancer research projects, funded in collaboration with Children’s Cancer and Leukaemia Group (CCLG).
The LPT works with CCLG to fund research, using our expertise to select the most impactful research projects and manage their extensive research programme. With the latest seven projects, the LPT has funded over £25 million of research through the CCLG Research Funding Network.
Ashley Ball-Gamble, CEO of CCLG, said:
We are immensely proud to support the LPT in their research funding journey and witness their growing role as a significant funder of childhood cancer research.
The New Ideas projects highlight the importance of the LPT’s unique funding schemes, with the potential to inspire significant future research and make a real difference for children with cancer.
The New Ideas Grant scheme is specifically designed to support bold, innovative research in childhood cancer, focusing on early-stage projects that may struggle to find traditional funding. These projects aim to gather early evidence for ideas that could transform the way children with cancer are treated.
In 2024, the second year of the New Ideas grant scheme, the LPT has funded more than twice the number of projects funded in 2023.
Phil Brace, CEO of the LPT, said:
This year, we are thrilled to have funded seven outstanding projects - four more than last year! The expansion of our New Ideas grant scheme demonstrates our commitment to advancing children's cancer research.
It is especially exciting to see so many projects this year that take a multi-disease approach. These cross-cutting initiatives have the potential to benefit the entire childhood cancer research field and, we hope, improve outcomes for many more young patients.
The 2024 New Ideas Grants
- Rewriting cancer cell messages to slow down tumour growth: Professor Karim Malik at the University of Bristol
- Understanding how a new drug called can selectively fight childhood cancer cells: Dr Igor Vivanco at King’s College London
- Understanding how immune cells around the brain protect childhood ependymoma tumours: Dr Elizabeth Cooper at the University of Cambridge
- Understanding how childhood cancers spread: Dr Madhumita Dandapani at the University of Nottingham
- Cracking the code - understanding how neuroblastoma and immune cells join forces to improve treatment: Dr Alejandra Bruna at the Institute of Cancer Research
- Fighting circular DNA as a new way to prevent relapse in acute lymphoblastic leukaemia: Dr Joan Boyes at the University of Leeds
- Making an ‘off-the-shelf’ CAR-T cell treatment for children with solid cancers: Professor John Anderson at UCL Great Ormond Street Institute of Child Health